Heparan sulfate D-glucosaminyl 3-O-sulfotransferase-3B1, a novel epithelial-mesenchymal transition inducer in pancreatic cancer

Cancer Biology and Therapy

Volumn 12, Issue 5, 2011, Pages 388-398

  Song, Kai ^a   Li, Qin ^a   Jiang, Zhen Zhen ^a   Guo, Chao Wei ^a   Li, Ping ^a  

^a CHINA PHARMACEUTICAL UNIVERSITY   (China)

Author keywords

3 O sulfotransferase; Angiogenesis; EMT; Heparan sulfate; Histone acetylation; Snail

Indexed keywords

HEPARAN SULFATE DEXTRO GLUCOSAMINYL 3 O SULFOTRANSFERASE 3B1; HISTONE H3; LYSINE; MESSENGER RNA; SULFOTRANSFERASE; TRANSCRIPTION FACTOR SNAIL; TRICHOSTATIN A; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CARCINOGENESIS; CELL NUCLEUS; CHROMATIN IMMUNOPRECIPITATION; CONTROLLED STUDY; EPITHELIAL MESENCHYMAL TRANSITION; GENE FUNCTION; GENE INDUCTION; HISTONE ACETYLATION; HISTONE MODIFICATION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; PANCREAS CANCER; PROTEIN LOCALIZATION; PROTEIN TRANSPORT; TRANSCRIPTION INITIATION; UPREGULATION;

AZACITIDINE; BASE SEQUENCE; CELL LINE, TUMOR; CHROMATIN IMMUNOPRECIPITATION; ENDOTHELIAL CELLS; EPITHELIAL-MESENCHYMAL TRANSITION; HEPARITIN SULFATE; HISTONES; HUMANS; HYDROXAMIC ACIDS; METHYLATION; PANCREATIC NEOPLASMS; RNA, MESSENGER; SEQUENCE ANALYSIS, DNA; SULFOTRANSFERASES; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION;

EID: 80052357047     PISSN: 15384047     EISSN: 15558576     Source Type: Journal    
DOI: 10.4161/cbt.12.5.15957     Document Type: Article

References (32)

1. Thiery J.P., Sleeman JP. Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol 2006; 7:131-42; PMID: 16493418; DOI: 10.1038/nrm1835.
2. Wang Z., Li Y., Kong D., Banerjee S., Ahmad A., Azmi A.S., et al. Acquisition of epithelial-mesenchymal transition phenotype of gemcitabine-resistant pancreatic cancer cells is linked with activation of the notch signaling pathway. Cancer Res 2009; 69:2400-7; PMID: 19276344; DOI: 10.1158/0008-5472.CAN-08-4312.
3. Bishop J.R., Schuksz M., Esko JD. Heparan sulphate proteoglycans fine-tune mammalian physiology. Nature 2007; 446:1030-7; PMID: 17460664; DOI: 10.1038/ nature05817.
4. Esko J.D., Rostand K.S., Weinke JL. Tumor formation dependent on proteoglycan biosynthesis. Science 1988; 241:1092-6; PMID: 3137658; DOI: 10.1126/science. 3137658.
5. Girardin E.P., Hajmohammadi S., Birmele B., Helisch A., Shworak N.W., De Agostini AI. Synthesis of anticoagulantly active heparan sulfate proteoglycans by glomerular epithelial cells involves multiple 3-O-sulfotransferase isoforms and a limiting precursor pool. J Biol Chem 2005; 280:38059-70; PMID: 16107334; DOI: 10.1074/jbc.M507997200.
6. Xu D., Moon A.F., Song D., Pedersen L.C., Liu J. Engineering sulfotransferases to modify heparan sulfate. Nat Chem Biol 2008; 4:200-2; PMID: 18223645; DOI: 10.1038/nchembio.66.
7. Vanpouille C., Deligny A., Delehedde M., Denys A., Melchior A., Lienard X., et al. The heparin/heparan sulfate sequence that interacts with cyclophilin B contains a 3-O-sulfated N-unsubstituted glucosamine residue. J Biol Chem 2007; 282:24416-29; PMID: 17588944; DOI: 10.1074/jbc.M701835200.
8. Lawrence R., Yabe T., Hajmohammadi S., Rhodes J., McNeely M., Liu J., et al. The principal neuronal gDtype 3-O-sulfotransferases and their products in central and peripheral nervous system tissues. Matrix Biol 2007; 26:442-55; PMID: 17482450; DOI: 10.1016/j. matbio.2007.03.002.
9. Staub J., Chien J., Pan Y., Qian X., Narita K., Aletti G., et al. Epigenetic silencing of HSulf-1 in ovarian cancer: implications in chemoresistance. Oncogene 2007; 26:4969-78; PMID: 17310998; DOI: 10.1038/ sj.onc.1210300.
10. Bui C., Ouzzine M., Talhaoui I., Sharp S., Prydz K., Coughtrie M.W., et al. Epigenetics: methylation-associated repression of heparan sulfate 3-O-sulfotransferase gene expression contributes to the invasive phenotype of H-EMC-SS chondrosarcoma cells. FASEB J 2010; 24:436-50; PMID: 19812376; DOI: 10.1096/fj.09-136291.
11. Miyamoto K., Asada K., Fukutomi T., Okochi E., Yagi Y., Hasegawa T., et al. Methylation-associated silencing of heparan sulfate D-glucosaminyl 3-O-sulfotransferase-2 (3-OST-2) in human breast, colon, lung and pancreatic cancers. Oncogene 2003; 22:274-80; PMID: 12527896; DOI: 10.1038/sj.onc.1206146.
12. Shteper P.J., Zcharia E., Ashhab Y., Peretz T., Vlodavsky I., Ben-Yehuda D. Role of promoter methylation in regulation of the mammalian heparanase gene. Oncogene 2003; 22:7737-49; PMID: 14586400; DOI: 10.1038/ sj.onc.1207056.
13. Ehrlich M. DNA methylation in cancer: too much, but also too little. Oncogene 2002; 21:5400-13; PMID: 12154403; DOI: 10.1038/sj.onc.1205651.
14. Kaneda A., Tsukamoto T., Takamura-Enya T., Watanabe N., Kaminishi M., Sugimura T., et al. Frequent hypomethylation in multiple promoter CpG islands is associated with global hypomethylation, but not with frequent promoter hypermethylation. Cancer Sci 2004; 95:58-64; PMID: 14720328; DOI: 10.1111/j.1349- 7006.2004.tb03171.x.
15. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007; 8:286-98; PMID: 17339880; DOI: 10.1038/nrg2005.
16. Glozak M.A., Seto E. Histone deacetylases and cancer. Oncogene 2007; 26:5420-32; PMID: 17694083; DOI: 10.1038/sj.onc.1210610.
17. Maison C., Bailly D., Peters A.H., Quivy J.P., Roche D., Taddei A., et al. Higher-order structure in pericentric heterochromatin involves a distinct pattern of histone modification and an RNA component. Nat Genet 2002; 30:329-34; PMID: 11850619; DOI: 10.1038/ng843.
18. Shia W.J., Pattenden S.G., Workman JL. Histone H4 lysine 16 acetylation breaks the genome's silence. Genome Biol 2006; 7:217; PMID: 16689998; DOI: 10.1186/gb-2006-7-5-217.
19. Seranski P., Heiss N.S., Dhorne-Pollet S., Radelof U., Korn B., Hennig S., et al. Transcription mapping in a medulloblastoma breakpoint interval and Smith- Magenis syndrome candidate region: identification of 53 transcriptional units and new candidate genes. Genomics 1999; 56:1-11; PMID: 10036180; DOI: 10.1006/geno.1998.5647.
20. Li L.C., Dahiya R. MethPrimer: designing primers for methylation PCRs. Bioinformatics 2002; 18:1427- 31; PMID: 12424112; DOI: 10.1093/bioinformatics/ 18.11.1427.
21. Noseda M., McLean G., Niessen K., Chang L., Pollet I., Montpetit R., et al. Notch activation results in phenotypic and functional changes consistent with endothelial-to-mesenchymal transformation. Circ Res 2004; 94:910-7; PMID: 14988227; DOI: 10.1161/01.RES.0000124300.76171.C9.
22. Lee J.M., Dedhar S., Kalluri R., Thompson EW. The epithelial-mesenchymal transition: new insights in signaling, development and disease. J Cell Biol 2006; 172:973-81; PMID: 16567498; DOI: 10.1083/ jcb.200601018.
23. Peinado H., Olmeda D., Cano A. Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat Rev Cancer 2007; 7:415-28; PMID: 17508028; DOI: 10.1038/nrc2131.
24. Niessen K., Fu Y., Chang L., Hoodless P.A., McFadden D., Karsan A. Slug is a direct Notch target required for initiation of cardiac cushion cellularization. J Cell Biol 2008; 182:315-25; PMID: 18663143; DOI: 10.1083/ jcb.200710067.
25. Lin X., Chen X., Wei Y., Zhao J., Fan L., Wen Y., et al. Efficient inhibition of intraperitoneal human ovarian cancer growth and prolonged survival by gene transfer of vesicular stomatitis virus matrix protein in nude mice. Gynecol Oncol 2007; 104:540-6; PMID: 17112567; DOI: 10.1016/j.ygyno.2006.09.022.
26. Kleeff J., Ishiwata T., Kumbasar A., Friess H., Buchler M.W., Lander A.D., et al. The cell-surface heparan sulfate proteoglycan glypican-1 regulates growth factor action in pancreatic carcinoma cells and is overexpressed in human pancreatic cancer. J Clin Invest 1998; 102:1662- 73; PMID: 9802880; DOI: 10.1172/JCI4105.
27. Ding K., Lopez-Burks M., Sanchez-Duran J.A., Korc M., Lander AD. Growth factor-induced shedding of syndecan- 1 confers glypican-1 dependence on mitogenic responses of cancer cells. J Cell Biol 2005; 171:729-38; PMID: 16286510; DOI: 10.1083/jcb.200508010.
28. Kleeff J., Wildi S., Kumbasar A., Friess H., Lander A.D., Korc M. Stable transfection of a glypican-1 antisense construct decreases tumorigenicity in PANC-1 pancreatic carcinoma cells. Pancreas 1999; 19:281-8; PMID: 10505759; DOI: 10.1097/00006676-199910000-00009.
29. Bachelder R.E., Yoon S.O., Franci C., De Herreros A.G., Mercurio AM. Glycogen synthase kinase-3 is an endogenous inhibitor of Snail transcription: implications for the epithelial-mesenchymal transition. J Cell Biol 2005; 168:29-33; PMID: 15631989; DOI: 10.1083/ jcb.200409067.
30. Sahlgren C., Gustafsson M.V., Jin S., Poellinger L., Lendahl U. Notch signaling mediates hypoxia-induced tumor cell migration and invasion. Proc Natl Acad Sci USA 2008; 105:6392-7; PMID: 18427106; DOI: 10.1073/pnas.0802047105.
31. Geiger T.R., Peeper DS. Metastasis mechanisms. Biochim Biophys Acta 2009; 1796:293-308; PMID: 19683560.
32. Herman J.G., Graff J.R., Myohanen S., Nelkin B.D., Baylin SB. Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 1996; 93:9821-6; PMID: 8790415; DOI: 10.1073/pnas.93.18.9821.